Literature DB >> 30020049

Immuno-checkpoint inhibitor-associated hyper-eosinophilia and tumor shrinkage.

Hajime Osawa1, Shinichiro Okauchi1, Shijima Taguchi2, Katsunori Kagohashi1, Hiroaki Satoh1.   

Abstract

Entities:  

Year:  2018        PMID： 30020049     DOI： 10.5578/tt.66667

Source DB:  PubMed          Journal:  Tuberk Toraks        ISSN： 0494-1373


× No keyword cloud information.
  2 in total

1.  Absolute Increase in the Number and Proportion of Peripheral Eosinophils Associated With Immune Checkpoint Inhibitor Treatment in Non-small Cell Lung Cancer Patients.

Authors:  Hajime Osawa; Toshihiro Shiozawa; Shinichiro Okauchi; Yuika Sasatani; Gen Ohara; Shinya Sato; Kunihiko Miyazaki; Takahide Kodama; Katsunori Kagohashi; Hiroaki Satoh; Nobuyuki Hizawa
Journal:  Cancer Diagn Progn       Date:  2021-11-03

2.  Severe eosinophilia and subsequent dermatologic immune-related adverse event with squamous cell carcinoma antigen elevation induced by nivolumab and ipilimumab.

Authors:  Takeshi Matsumoto; Akiko Kaneko; Yusuke Kusakabe; Emi Nakayama; Ayaka Tanaka; Naoki Yamamoto; Kensaku Aihara; Shinpachi Yamaoka; Michiaki Mishima
Journal:  Respirol Case Rep       Date:  2022-09-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.